Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral:** * For mild hypokalemia or prevention: 20-40 mEq (1.5-3 g KCl) per day, divided into 1-2 doses. * For moderate to severe hypokalemia: 40-100 mEq (3-7.5 g KCl) per day, divided into 2-4 doses. Maximum daily dose generally does not exceed 100-120 mEq (7.5-9 g KCl). * **Intravenous:** * Dosing depends on serum potassium levels and clinical situation. * For moderate hypokalemia (serum K 2.5-3.5 mEq/L): 10-20 mEq (0.75-1.5 g KCl) added to a large volume IV fluid (e.g., 1000 mL NS or LR) infused over 2-6 hours. * For severe hypokalemia (serum K < 2.5 mEq/L): Can administer up to 20-40 mEq (1.5-3 g KCl) per hour in a critical care setting with continuous cardiac monitoring. **Maximum infusion rate is typically 20 mEq/hour, but up to 40 mEq/hour may be used in emergency situations with close monitoring.** * Total daily dose typically ranges from 40-100 mEq (3-7.5 g KCl), but may be higher in severe cases. **Maximum recommended daily IV dose is often 200 mEq (15 g KCl), but must be guided by clinical response and serum potassium levels.** ## Pediatric Dosing * Oral and IV dosing are highly individualized and depend on age, weight, and serum potassium levels. * **Oral:** Typical maintenance is 1-2 mEq/kg/day, not to exceed adult maximums. * **Intravenous:** Dosing is complex and often based on local protocols. Generally, 0.5-1 mEq/kg per dose may be administered. **Maximum infusion rate is crucial to prevent hyperkalemia and cardiac arrhythmias, typically not exceeding 10-20 mEq/hour unless in a critical care setting with continuous cardiac monitoring.** ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reduction is necessary. Monitor potassium closely. In severe renal impairment, potassium supplementation may be contraindicated. ## Contraindications * Hyperkalemia. * Conditions causing elevated potassium levels (e.g., untreated Addison's disease, severe renal impairment, conditions causing cellular shift of potassium). * Certain gastrointestinal conditions (e.g., esophageal compression, delayed gastric emptying, intestinal obstruction, peptic ulceration) when using solid oral dosage forms. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort. * **Serious:** Hyperkalemia (most significant risk), cardiac arrhythmias (including cardiac arrest), gastrointestinal ulceration, bleeding, perforation. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and ARBs (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs:** May reduce the antihypertensive effect of potassium chloride and increase risk of hyperkalemia. * **Anticholinergics:** May enhance GI absorption of oral potassium chloride, increasing risk of GI side effects. * **Digoxin:** Hyperkalemia can potentiate digoxin toxicity. Hypokalemia can increase digoxin toxicity. ## Monitoring * **Serum potassium levels:** Frequently, especially with IV administration, rapid correction, or in patients with renal impairment. * **Renal function (BUN, creatinine):** Essential, particularly in patients with known or suspected renal disease. * **ECG:** For signs of hyperkalemia (peaked T waves, prolonged PR interval, loss of P waves, sine wave pattern). * **Signs and symptoms of hyperkalemia:** Muscle weakness, paresthesias, confusion, bradycardia, hypotension. ## Clinical Pearls * Oral potassium chloride should be taken with meals and a full glass of water to minimize gastrointestinal irritation. * Do not crush or chew extended-release formulations. * Intravenous potassium chloride must be diluted before administration. **Never administer IV potassium chloride undiluted as an IV bolus due to the risk of cardiac arrest.** * Oral therapy is generally preferred for chronic hypokalemia to avoid the risks associated with IV administration. * Correction of hypokalemia should be gradual. Rapid correction can lead to dangerous hyperkalemia. * Ensure adequate magnesium levels, as hypomagnesemia can impair potassium repletion. *** **Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information or a reliable drug reference for complete and up-to-date drug information before making any treatment decisions. Dosing and administration may vary based on patient-specific factors and local institutional protocols.